Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype
Authors
Keywords
-
Journal
ONCOGENE
Volume 33, Issue 50, Pages 5666-5674
Publisher
Springer Nature
Online
2013-12-02
DOI
10.1038/onc.2013.508
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Androgen Receptor-Independent Function of FoxA1 in Prostate Cancer Metastasis
- (2013) H.-J. Jin et al. CANCER RESEARCH
- Forkhead-box A1 transcription factor is a novel adverse prognosis marker in human glioma
- (2013) Liang Wang et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Endogenous Purification Reveals GREB1 as a Key Estrogen Receptor Regulatory Factor
- (2013) Hisham Mohammed et al. Cell Reports
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man
- (2012) Naomi L. Sharma et al. CANCER CELL
- FoxA1 Specifies Unique Androgen and Glucocorticoid Receptor Binding Events in Prostate Cancer Cells
- (2012) B. Sahu et al. CANCER RESEARCH
- Opposite roles of FOXA1 and NKX2-1 in lung cancer progression
- (2012) Lena Deutsch et al. GENES CHROMOSOMES & CANCER
- Androgen receptor (AR) aberrations in castration-resistant prostate cancer
- (2012) Kati K. Waltering et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions
- (2012) Keith F. Decker et al. NUCLEIC ACIDS RESEARCH
- Non-Overlapping Progesterone Receptor Cistromes Contribute to Cell-Specific Transcriptional Outcomes
- (2012) Christine L. Clarke et al. PLoS One
- FOXA1 Promotes Tumor Progression in Prostate Cancer via the Insulin-Like Growth Factor Binding Protein 3 Pathway
- (2012) Yusuke Imamura et al. PLoS One
- FOXA1 Promotes Tumor Progression in Prostate Cancer and Represents a Novel Hallmark of Castration-Resistant Prostate Cancer
- (2011) Josefine Gerhardt et al. AMERICAN JOURNAL OF PATHOLOGY
- MEME-ChIP: motif analysis of large DNA datasets
- (2011) Philip Machanick et al. BIOINFORMATICS
- Definition of a FoxA1 Cistrome That Is Crucial for G1 to S-Phase Cell-Cycle Transit in Castration-Resistant Prostate Cancer
- (2011) C. Zhang et al. CANCER RESEARCH
- Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression
- (2011) Y. Li et al. CANCER RESEARCH
- Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer
- (2011) Biswajyoti Sahu et al. EMBO JOURNAL
- Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
- (2011) Jessica L L Robinson et al. EMBO JOURNAL
- High-level expression of forkhead-box protein A1 in metastatic prostate cancer
- (2011) Rohit K Jain et al. HISTOPATHOLOGY
- Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA
- (2011) Dong Wang et al. NATURE
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cooperative interaction between retinoic acid receptor- and estrogen receptor in breast cancer
- (2010) C. S. Ross-Innes et al. GENES & DEVELOPMENT
- FOXA1 is a key determinant of estrogen receptor function and endocrine response
- (2010) Antoni Hurtado et al. NATURE GENETICS
- The rs10993994 Risk Allele for Prostate Cancer Results in Clinically Relevant Changes in Microseminoprotein-Beta Expression in Tissue and Urine
- (2010) Hayley C. Whitaker et al. PLoS One
- TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells
- (2009) Misato Kikuchi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
- (2009) Qianben Wang et al. CELL
- FOXA1 Is a Potential Oncogene in Anaplastic Thyroid Carcinoma
- (2009) C. Nucera et al. CLINICAL CANCER RESEARCH
- ChIP-seq: Using high-throughput sequencing to discover protein–DNA interactions
- (2009) Dominic Schmidt et al. METHODS
- BASH: a tool for managing BeadArray spatial artefacts
- (2008) J. M. Cairns et al. BIOINFORMATICS
- FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific Transcription
- (2008) Mathieu Lupien et al. CELL
- STRING 8--a global view on proteins and their functional interactions in 630 organisms
- (2008) L. J. Jensen et al. NUCLEIC ACIDS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started